The addictive brain: All roads lead to dopamine

Journal of Psychoactive Drugs

Volumn 44, Issue 2, 2012, Pages 134-143

  Blum, Kenneth ^{a,c,d,e,f,g,i}   Cshen, Amanda L C ^b   Giordano, John ^c   Borsten, Joan ^d   Chen, Thomas J H ^b   Hauser, Mary ^e   Simpatico, Thomas ^f   Femino, John ^c   Braverman, Eric R ^g,h   Barh, Debmalya ⁱ  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^c Department of Holistic Medicine G and G Holistic Addiction Treatment Center ^*

^d Malibu Beach Recovery Center   (United States)

^e Dominion Diagnostics   (United States)

^f UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^g PATH Foundation   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ Institute of Integrative Omics and Applied Biotechnology IIOAB   (India)

Author keywords

Brain reward cascade; Dopamine; Mesolimbic system; Orbital prefrontal cortex cingulate gyrus; Relapse; Reward deficiency syndrome (RDS)

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR;

ADDICTION; ARTICLE; BRAIN FUNCTION; DOPAMINE D2 RECEPTOR GENE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HUMAN; PLEASURE; ANIMAL; BRAIN; GENETIC PREDISPOSITION; METABOLISM; MOLECULAR EVOLUTION; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; DOPAMINE; EVOLUTION, MOLECULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PLEASURE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RISK ASSESSMENT; RISK FACTORS; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS;

EID: 84865373474     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2012.685407     Document Type: Article

References (41)

1. American Society of Addiction Medicine (ASAM). 2011. Public Policy Statement-Definition of Addiction. Available at: http://www.asam.org/advocacy/find-a-policy-statement/view-policy-statement/public-policy-statements/2011/12/15/the-definition-of-addiction.
2. Berger, L.R.; de Ruiter, D.J.; Churchill, S.E.; Schmid, P.; Carlson, K.J.; Dirks, P.H. & Kibii, J.M. 2010. Australopithecus sediba: A new species of Homo-like australopith from South Africa. Science 328 (5975): 195-204.
3. Benes, F.M. 2001. Carlsson and the discovery of dopamine. Trends in Pharmacological Sciences 22 (1): 46-47.
4. Blum, K. 2011. Neurogenetics and nutrigenomics of reward deficiency syndrome. In: D. Barh; K. Blum & M. Madigan (Eds) Omics: Biomedical Perspectives and Applications. Boca Roton, FL: CRC Press.
5. Blum, K.; Werner, T.; Carnes, S.; Carnes, P.; Bowirrat, A.; Giordano, J. & Gold, M.S. 2012. Sex, drugs and rock 'n' roll: Hypothesizing common mesolimbic activation as a function of reward gene polymorphisms. Journal of Psychoactive Drugs 44 (1): 38-55.
6. Blum, K.; Liu, Y.; Shriner, R. & Gold, M.S. 2011. Reward circuitry dopaminergic activation regulates food and drug craving behavior. Current Pharmaceutical Design 17 (12): 1158-67.
7. Blum, K.; Giordano, J.; Morse, S.; Anderson, A.; Carbajal, J.; Waite, R.; Downs, B.W.; Downs, J.; Madigan, M.; Barh, D. & Braverman, E. 2011. Hypothesizing synergy between acupuncture/ auriculotherapy and natural activation of mesolimbic dopaminergic pathways: Putative natural treatment modalities for the reduction of drug hunger and relapse. Integrative Omics and Applied Biotechnology Letters 1: 8-20.
8. Blum, K.; Giordano, J.; Morse, S.; Liu, Y.; Tan, J.; Bowirrat, A.; Smolen, A.; Waite, R.; Downs, B.W.; Madigan, M.; Kerner, M.; Fornari, F.; Stice, E.; Braverman, E.; Miller, D. & Bailey, J.A. 2010. Genetic Addiction Risk Score (GARS) analysis: Exploratory development of polymorphic risk alleles in poly-drug addicted males. Integrative Omics and Applied Biotechnology 1 (2): 1-14.
9. Blum, K.; Braverman E.R.; Holder, J.M.; Lubar, J.F.; Monastra, V.J.; Miller, D.; Lubar, J.O.; Chen, T. J. & Comings, D.E. 2000. Reward deficiency syndrome: A biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. Journal of Psychoactive Drugs 32 (Suppl): 1-112.
10. Blum, K.; Sheridan, P.J.; Wood, R.C.; Braverman, E.R.; Chen, T.J.; Cull, J.G. & Comings, D.E. 1996a. The D2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome. Journal of the Royal Society of Medicine 89 (7): 396-400.
11. Blum, K.; Cull, J.; Braverman, E. & Comings, D. 1996b. Reward deficiency syndrome. American Scientist. 84: 132-45.
12. Blum, K.; Noble, E.P; Sheridan, P.J.; Montgomery, A.; Ritchie, T.; Jagadeeswaran, P; Nogami, H.; Briggs, A.H. & Cohn, J.B. 1990. Allelic association of human dopamine D2 receptor gene in alcoholism. Journal of the American Medical Association 263 (15): 2055-60.
13. Budygin, E.A.; Park, J.; Bass, C.E.; Grinevich, V.P.; Bonin, K.D. & Wightman, R.M. 2012. Aversive stimulus differentially triggers subsecond dopamine release in reward regions. Neuroscience 201: 331-37.
14. Castiglione, C. M.; Deinard, A.S.; Speed, W.C.; Sirugo, G.; Rosenbaum, H.C.; Zhang, Y.; Grandy, D.K.; Grigorenko, E.L. Bonne-Tamir, B.; Pakstis, A.J.; Kidd, J.R. & Kidd K.K. 1995. Evolution of haplotypes at the DRD2 locus. Journal of Human Genetics 57 (6): 1445-56.
15. Chen, T.J.; Blum, K.; Chen, A.L.; Bowirrat, A.; Downs, W.B.; Madigan, M.A.; Waite, R.L.; Bailey, J.A.; Kerner, M.; Yeldandi, S.; Majmundar, N.; Giordano, J.; Morse, S.; Miller, D.; Fornari, F. & Braverman, E.R. 2011. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: Proposing an addiction candidate gene panel map. Journal of Psychoactive Drugs 43 (2): 108-27.
16. Comings, D.E. 2008. Did Man Create God? Duarte, CA: Hope Press.
17. Comings, D.E. 1996. The Gene Bomb. Duarte, CA: Hope Press.
18. Davis, P.F.; Ozias, M.K.; Carlson, S.E.; Reed, G.A.; Winter, M.K.; McCarson, K.E. & Levant, B. 2010. Dopamine receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): Interactions with reproductive status. Nutrition and Neuroscience 13 (4):161-69.
19. DuPont, R.L.; McLellan, A.T.; Carr, G.; Gendel, M. & Skipper, G.E. 2009. How are addicted physicians treated? A national survey of physician health programs. Journal of Substance Abuse Treatment 37: 1-7.
20. Erickson C. 2007. The Science of Addiction. New York: W.W. Norton & Co.
21. Fowler, J.H.; Settle, J.E. & Christakis, N.A. 2011. Correlated genotypes in friendship networks. Proceedings of the National Academy of Sciences U S A 108 (5): 1993-97.
22. Georgiadis, J.R.; Kortekaas, R.; Kuipers, R.; Nieuwenburg, A.; Pruim, J.; Reinders, A.A. & Holstege, G. 2006. Regional cerebral blood flow changes associated with clitorally induced orgasm in healthy women. European Journal of Neuroscience 24 (11): 3305-16.
23. Giordano, J. & Blum, K. 2010. Probing the mysteries of recovery through nutrigenomics and holistic medicine: Science meets recovery. Counselor 17: 52.
24. Hamer, D. 2005. The God Gene. New York: Doubleday.
25. Kirsch, P.; Reuter, M.; Mier, D.; Lonsdorf, T.; Stark, R.; Gallhofer, B.; Vaitl, D. & Hennig, J. 2006. Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neuroscience Letters 405 (3): 196-201.
26. Kjaer, T.W.; Bertelsen, C.; Piccini, P.; Brooks, D.; Alving, J. & Lou, H.C. 2002. Increased dopamine tone during meditation-induced change of consciousness. Brain Research Cognitive Brain Research 13 (2): 255-59.
27. Kuperstein, F.; Yakubov, E.; Dinerman, P.; Gil, S.; Eylam, R.; Salem, N. Jr. & Yavin, E. 2005. Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n- 3 fatty acid dietary deficiency. Journal of Neurochemistry 95 (6): 1550-62.
28. McLellan, A.T.; Lewis, D.C.; O'Brien, C.P, & Kleber, H.D. 2000. Drug dependence a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association 284 (13): 1689-95.
29. Morse, S.; Giordano, J.; Perrine, K.; Downs, B.W.; Waite, R.L.; Madigan, M.; Bailey, J.; Braverman, E.R.; Damle, U.; Knopf, J.; Simpatico, T.; Moeller, M.; Barh, D. & Blum, K. 2011. Audio therapy significantly attenuates aberrant mood in residential patient addiction treatment: Putative activation of dopaminergic pathways in the mesolimbic reward circuitry of humans. Addiction Research & Therapy. Available at http://www.omicsonline.org/2155-6105/2155-6105-S3-001.php.
30. National Institute on Drug Abuse (NIDA). 2010. Research Reports: Cocaine: Abuse and Addiction. Available at http://www.drugabuse.gov/publications/research-reports/cocaine-abuse-addiction.
31. Noble, E.P.; Blum, K.; Ritchie, T.; Montgomery, A. & Sheridan, P.J. 1991. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Archives of General Psychiatry 48 (7): 648-54.
32. Pickens, R.W.; Svikis, D.S.; McGue, M.; Lykken, D.T.; Heston, L.L. & Clayton, P.J. 1991. Heterogeneity in the inheritance of alcoholism. A study of male and female twins. Archives of General Psychiatry 48 (1): 19-28.
33. Previc, F. 2009. The DopaminergicMind in Human Evolution and History. Oxford: Cambridge University Press.
34. Raghanti, M.A.; Stimpson, C.D.; Marcinkiewicz, J.L.; Erwin, J.M.; Hof, P.R. & Sherwood, C.C. 2008. Cortical dopaminergic innervations among humans, chimpanzees, and macaque monkeys: A comparative study. Neuroscience 155 (1): 203-20
35. Rapoport, S.I. 1990. Integrated phylogeny of the primate brain with special reference to humans and their diseases. Brain Research Reviews 15 (3): 267-94.
36. Ross, H.E. & Young, L.J. 2009. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Frontiers in Neuroendocrinology 30 (4): 534-47.
37. Sturges, C.S. 1993. Dr. Dave: A Profile of David E. Smith, M.D. Walnut Creek, CA: Devil Mountain Books.
38. Sussman, S. & Sussman, A.N. 2011. Considering the definition of addiction. International Journal of Environmental Research and Public Health 8 (10): 4025-38.
39. Thanos, P.K.; Michaelides, M.; Umegaki, H. & Volkow, N.D. 2008. D2R DNA transfer into the nucleus accumbens attenuates cocaine selfadministration in rats. Synapse 62 (7): 481-86.
40. U.S. Census Bureau. 2011. USA QuickFacts. Available at http://quickfacts.census.gov/qfd/states/00000.html
41. U.S. Department of Health & Human Services (US DHHS). 2008. Alcohol Alert. 76: July.